Cancer Clinical Trial
— THRIVEOfficial title:
mHealth Physical Activity Intervention for Survivors of Adolescent and Young Adult Cancers
Verified date | May 2023 |
Source | UNC Lineberger Comprehensive Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to examine the feasibility, acceptability, and gather preliminary data on outcomes of a 3-month mHealth intervention to promote physical activity among adolescent and young adult (AYA) cancer survivors compared to a delayed intervention control group.
Status | Completed |
Enrollment | 64 |
Est. completion date | March 25, 2019 |
Est. primary completion date | March 25, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 39 Years |
Eligibility | Inclusion Criteria: - Diagnosed with cancer (excluding basal cell skin cancer) at age 15 or older - Currently age 18-39 - Are 0 to 10 years post active cancer treatment (i.e., current hormonal treatments or maintenance therapies are permissible) - Able to speak, read and write English - Have access to the Internet and computer on at least a weekly basis - Possession and usage of an Internet e-mail address or willingness to sign up for a free email account - Have active Facebook account - Willing to be randomized to either arm Exclusion Criteria: - History of heart attack or stroke within past 6 months - Untreated hypertension, hyperlipidemia, or diabetes, unless permission is provided by their health care provider - Have a pre-existing medical condition(s) or contraindications that preclude adherence to an unsupervised exercise program, including cardiovascular disease, heart failure, pulmonary conditions, renal disease, and severe orthopedic conditions - Are already adhering to the American Cancer Society's recommendation of =150 minutes of moderate-intensity exercise per week (<150 minutes/week) - Current participation in another physical activity or weight control program - Currently pregnant, pregnant within the past 6 months, or planning to become pregnant within the next 6 months - Plans for major surgery (e.g., breast reconstruction) during the study time frame |
Country | Name | City | State |
---|---|---|---|
United States | University of North Carolina at Chapel Hill | Chapel Hill | North Carolina |
United States | Duke University Medical Center | Durham | North Carolina |
United States | Wake Forest University School of Medicine | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
UNC Lineberger Comprehensive Cancer Center | Wake Forest University Health Sciences |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Posttraumatic growth | Change in posttraumatic growth, as measured by the Short Form of the Posttraumatic Growth Inventory, from baseline to 3 months, and 3 months to 6 months. Responses range from 0 to 5 and yield an overall score and subscale scores for relating to others, new possibilities, personal strength, spiritual change, and appreciation of life. Items are summed, with higher scores reflecting more positive change (i.e., posttraumatic growth). | Baseline, 3 months, 6 months | |
Other | Positive psychosocial illness impact | Changes in positive psychosocial impact of illness, as measured by the PROMIS Psychosocial Illness Impact - Positive (4a), from baseline to 3 months, and 3 months to 6 months. Responses to the 4-item short from range from 1 to 5. Items are summed, with higher scores reflecting more positive psychosocial impact. | Baseline, 3 months, 6 months | |
Other | Negative psychosocial illness impact | Changes in positive psychosocial impact of illness, as measured by the PROMIS Psychosocial Illness Impact - Negative (4a), from baseline to 3 months, and 3 months to 6 months. Responses to the 4-item short from range from 1 to 5. Items are summed, with higher scores reflecting more negative psychosocial impact. | Baseline, 3 months, 6 months | |
Other | Positive affect | Changes in positive affect, as measured by the NIH Toolbox Positive Affect Short Form, from baseline to 3 months, and 3 months to 6 months. | Baseline, 3 months, 6 months | |
Other | Social network orientation | Changes in positive affect, as measured by the Network Orientation Scale, from baseline to 3 months, and 3 months to 6 months. Responses to 20 items range from 1 to 4. Items are summed (range: 20 to 80), with higher scores representing a more negative social network orientation. | Baseline, 3 months, 6 months | |
Primary | Accrual rate | Number of participants who agreed to participate divided by the number of months of recruitment. | Through completion of study enrollment, an average of 6 months. | |
Primary | Participation rate | Percentage of eligible participants who agreed to participate. | Through completion of study enrollment, an average of 6 months. | |
Primary | Retention rate at 3 months | Number of intervention participants who completed 3-month measures divided by the number who consented to participate. | 3 months | |
Secondary | Retention rate at 6 months | Number of intervention participants who completed 6-month measures divided by the number randomized to the intervention group. | 6 months | |
Secondary | Satisfaction with intervention | Ratings of satisfaction with the intervention, as measured by satisfaction questionnaire. | 6 months | |
Secondary | Adherence to physical activity monitoring | Number of days physical activity tracked, as measured by Fitbit. | Through study completion, 6 months | |
Secondary | Physical activity: objective | Change in objective levels of physical activity, as measured by accelerometry (Actigraph), from baseline to 3 months, and 3 months to 6 months. | Baseline, 3 months, 6 months | |
Secondary | Physical activity: self-report | Change in self-report levels of physical activity, as measured by the Godin Leisure Time Exercise Questionnaire, from baseline to 3 months, and 3 months to 6 months. | Baseline, 3 months, 6 months | |
Secondary | Sedentary behavior: self-report | Change in self-report levels of sedentary behavior, as measured by the Marshall Sitting Time Questionnaire, from baseline to 3 months, and 3 months to 6 months. | Baseline, 3 months, 6 months | |
Secondary | Weight | Change in self-reported weight, from baseline to 3 months, and 3 months to 6 months. | Baseline, 3 months, 6 months | |
Secondary | Intrinsic motivation | Change in intrinsic motivation, as measured by the intrinsic motivation subscale of the Treatment Self-Regulation Questionnaire for Exercise, from baseline to 3 months, and 3 months to 6 months. Responses to four items comprising intrinsic motivation subscale are averaged to yield a score from 1 to 7, with higher values representing higher intrinsic motivation. | Baseline, 3 months, 6 months | |
Secondary | Self-efficacy for exercise | Change in self-efficacy for exercise, as measured by the Self-Efficacy and Exercise Habits Survey, from baseline to 3 months, and 3 months to 6 months. Responses for two subscales (Sticking to it, Making time for exercise) are averaged to yield a score from 1 to 5, with higher values representing higher self-efficacy for exercise. | Baseline, 3 months, 6 months | |
Secondary | Social support for exercise | Change in social support for exercise, as measured by the Social Support for Exercise Survey, from baseline to 3 months, and 3 months to 6 months. Responses for three factors (Family participation, Friend participation, Friends on social networking sites participation), ranging from 1 to 5, are summed, with higher values representing higher social support for exercise. | Baseline, 3 months, 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|